Z1 Hip System: Post-Market Clinical Follow Up Study
NCT07104279
This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The objectives of this study are to confirm the early to mid- term safety, performance, and clinical benefits of the Z1 Femoral Hip System in hemi- and primary total hip arthroplasty. Cohort 0 The primary endpoint is defined by the survival of the implant system at 2 years, which is based on the absence of removal of the study device and will be evaluated using a one-sample proportion as well as using the Kaplan Meier method.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hip Osteoarthritis
- Acute Traumatic Fracture of the Femoral Head or Neck
- Avascular Necrosis of the Femoral Head
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Zimmer Biomet
- Last updated on ClinicalTrials.gov
- October 16, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Missouri · 1
- Mokan Orthopedic Research and Consulting · Platte City, MO
North Carolina · 1
- OrthoCarolina/OrthoCarolina Research Institute · Charlotte, NC
Ohio · 1
- Cleveland Clinic · Cleveland, OH
Oregon · 1
- Orthopedic & Fracture Specialists · Portland, OR
Virginia · 1
- Anderson Orthopaedic/Anderson Orthopaedic Research Institute · Alexandria, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.